These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 36077614)
1. DNA Polymerase Theta Plays a Critical Role in Pancreatic Cancer Development and Metastasis. Smolinska A; Singer K; Golchert J; Smyczynska U; Fendler W; Sendler M; van den Brandt J; Singer S; Homuth G; Lerch MM; Moskwa P Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077614 [TBL] [Abstract][Full Text] [Related]
2. Talazoparib enhances resection at DSBs and renders HR-proficient cancer cells susceptible to Polθ inhibition. Lin X; Soni A; Hessenow R; Sun Y; Mladenov E; Guberina M; Stuschke M; Iliakis G Radiother Oncol; 2024 Aug; 200():110475. PubMed ID: 39147034 [TBL] [Abstract][Full Text] [Related]
3. The Loss of ATRX Increases Susceptibility to Pancreatic Injury and Oncogenic KRAS in Female But Not Male Mice. Young CC; Baker RM; Howlett CJ; Hryciw T; Herman JE; Higgs D; Gibbons R; Crawford H; Brown A; Pin CL Cell Mol Gastroenterol Hepatol; 2019; 7(1):93-113. PubMed ID: 30510993 [TBL] [Abstract][Full Text] [Related]
4. ANGPTL4 accelerates KRAS Yan HH; Jung KH; Lee JE; Son MK; Fang Z; Park JH; Kim SJ; Kim JY; Lim JH; Hong SS Cancer Lett; 2021 Oct; 519():185-198. PubMed ID: 34311032 [TBL] [Abstract][Full Text] [Related]
5. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models. Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057 [TBL] [Abstract][Full Text] [Related]
6. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16. Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115 [TBL] [Abstract][Full Text] [Related]
13. Nucleoside Analogs Radiosensitize G0 Cells by Activating DNA End Resection and Alternative End-Joining. Magin S; Meher PK; Iliakis G Radiat Res; 2021 May; 195(5):412-426. PubMed ID: 33755161 [TBL] [Abstract][Full Text] [Related]
14. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues. Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419 [TBL] [Abstract][Full Text] [Related]
15. Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression. Li Z; Shao C; Liu X; Lu X; Jia X; Zheng X; Wang S; Zhu L; Li K; Pang Y; Xie F; Lu Y; Wang Y Carcinogenesis; 2020 Mar; 41(1):44-55. PubMed ID: 31046123 [TBL] [Abstract][Full Text] [Related]
16. Alternative end-joining repair pathways are the ultimate backup for abrogated classical non-homologous end-joining and homologous recombination repair: Implications for the formation of chromosome translocations. Iliakis G; Murmann T; Soni A Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():166-75. PubMed ID: 26520387 [TBL] [Abstract][Full Text] [Related]
17. Inactivation of APC Induces CD34 Upregulation to Promote Epithelial-Mesenchymal Transition and Cancer Stem Cell Traits in Pancreatic Cancer. Hsieh MJ; Chiu TJ; Lin YC; Weng CC; Weng YT; Hsiao CC; Cheng KH Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32586050 [TBL] [Abstract][Full Text] [Related]
18. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia. Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724 [TBL] [Abstract][Full Text] [Related]
19. Marked contribution of alternative end-joining to chromosome-translocation-formation by stochastically induced DNA double-strand-breaks in G2-phase human cells. Soni A; Siemann M; Pantelias GE; Iliakis G Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():2-8. PubMed ID: 26520366 [TBL] [Abstract][Full Text] [Related]